Karen Lewis - Jan 17, 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Sale	-$37.2K	-1.24K	-2.75%	$29.96	43.9K	Jan 17, 2025	Direct	F1
transaction	APLS	Common Stock	Award	$0	+28.5K	+65%	$0.00	72.4K	Jan 21, 2025	Direct	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
F2	This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.